biote Corp. (BTMD) has a MoatMap StockRank of 61/100 based on Quality (58/100), Value (63/100), and Momentum (25/100) factor scores. The current signal is HOLD. biote Corp is a micro-cap hormone therapy provider that lacks the scale, regulatory moat, or global distribution to fit our high-conviction portfolio.
biote Corp. is a healthcare company specializing in preventive medicine and hormone optimization therapies through its proprietary training, software, and pellet products. The company's competitive moat is its extensive network of trained, certified practitioners and a highly scalable, recurring-revenue business model. Biote operates as a market leader in the specialized field of bioidentical hormone replacement therapy.
| Price | $2.21 |
| Market Cap | $73M |
| P/E (TTM) | 5.49 |
| P/E (Forward) | 4.14 |
| Price/Book | -1.26 |
| Return on Invested Capital | 77.5% |
| Gross Margin | 70.1% |
| Operating Margin | 9.8% |
| Revenue Growth | -8.3% |
| Free Cash Flow | $-5M |
biote Corp. operates in the Medical Care Facilities industry, part of the Healthcare sector (United States).